187 related articles for article (PubMed ID: 24464743)
1. A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.
Campbell JD; Kell SA; Kozy HM; Lum JA; Sweetwood R; Chu M; Cunningham CR; Salamon H; Lloyd CM; Coffman RL; Hessel EM
Thorax; 2014 Jun; 69(6):565-573. PubMed ID: 24464743
[TBL] [Abstract][Full Text] [Related]
2. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
3. A prophylactic effect of an oligodeoxynucleotide containing a cytidine-guanosine motif against Japanese cedar pollen-induced T-helper type 2 allergic response.
Liu B; Zhang L; Liu J; Shan F; Wang E; Kimura Y
J Asthma; 2011 Nov; 48(9):974-8. PubMed ID: 21967528
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN.
Fonseca DM; Paula MO; Wowk PF; Campos LW; Gembre AF; Turato WM; Ramos SG; Dias-Baruffi M; Barboza R; Gomes E; Horn C; Marchal G; Arruda LK; Russo M; Bonato VL
Immunol Cell Biol; 2011 Oct; 89(7):777-85. PubMed ID: 21403663
[TBL] [Abstract][Full Text] [Related]
5. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides.
Hussain I; Jain VV; Kitagaki K; Businga TR; O'Shaughnessy P; Kline JN
Laryngoscope; 2002 Oct; 112(10):1819-26. PubMed ID: 12368622
[TBL] [Abstract][Full Text] [Related]
6. Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis.
Banerjee B; Kelly KJ; Fink JN; Henderson JD; Bansal NK; Kurup VP
Infect Immun; 2004 Oct; 72(10):6087-94. PubMed ID: 15385513
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of Chenopodium album induced asthma by intranasal administration of CpG oligodeoxynucleotides in BALB/c mice.
Mousavi T; Salek Moghadam A; Falak R
Iran J Immunol; 2008 Mar; 5(1):57-63. PubMed ID: 18319526
[TBL] [Abstract][Full Text] [Related]
8. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
[TBL] [Abstract][Full Text] [Related]
9. Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.
Rhee CS; Libet L; Chisholm D; Takabayashi K; Baird S; Bigby TD; Lee CH; Horner AA; Raz E
Immunology; 2004 Sep; 113(1):106-13. PubMed ID: 15312141
[TBL] [Abstract][Full Text] [Related]
10. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma.
Serebrisky D; Teper AA; Huang CK; Lee SY; Zhang TF; Schofield BH; Kattan M; Sampson HA; Li XM
J Immunol; 2000 Nov; 165(10):5906-12. PubMed ID: 11067952
[TBL] [Abstract][Full Text] [Related]
11. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides.
Sur S; Wild JS; Choudhury BK; Sur N; Alam R; Klinman DM
J Immunol; 1999 May; 162(10):6284-93. PubMed ID: 10229876
[TBL] [Abstract][Full Text] [Related]
12. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
13. Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.
Brandenberger C; Rowley NL; Jackson-Humbles DN; Zhang Q; Bramble LA; Lewandowski RP; Wagner JG; Chen W; Kaplan BL; Kaminski NE; Baker GL; Worden RM; Harkema JR
Part Fibre Toxicol; 2013 Jul; 10():26. PubMed ID: 23815813
[TBL] [Abstract][Full Text] [Related]
14. Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma.
Santeliz JV; Van Nest G; Traquina P; Larsen E; Wills-Karp M
J Allergy Clin Immunol; 2002 Mar; 109(3):455-62. PubMed ID: 11897991
[TBL] [Abstract][Full Text] [Related]
15. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
Chisholm D; Libet L; Hayashi T; Horner AA
J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
[TBL] [Abstract][Full Text] [Related]
16. Allergen challenge induces Ifng dependent GTPases in the lungs as part of a Th1 transcriptome response in a murine model of allergic asthma.
Dharajiya N; Vaidya S; Sinha M; Luxon B; Boldogh I; Sur S
PLoS One; 2009 Dec; 4(12):e8172. PubMed ID: 20027288
[TBL] [Abstract][Full Text] [Related]
17. FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma.
Dharajiya N; Vaidya SV; Murai H; Cardenas V; Kurosky A; Boldogh I; Sur SA
PLoS One; 2010 Feb; 5(2):e9337. PubMed ID: 20179765
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory CpG oligonucleotides abrogate allergic susceptibility in a murine model of maternal asthma transmission.
Fedulov A; Silverman E; Xiang Y; Leme A; Kobzik L
J Immunol; 2005 Oct; 175(7):4292-300. PubMed ID: 16177069
[TBL] [Abstract][Full Text] [Related]
19. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
20. Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome.
Wu HM; Xie QM; Zhao CC; Xu J; Fan XY; Fei GH
Life Sci; 2019 Dec; 239():117067. PubMed ID: 31738882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
